✦ LIBER ✦

Final Results from Phase II Trial of Neoadjuvant Docetaxel and Capecitabine Given Sequentially or Concurrently for HER2-Negative Breast Cancers

✍ Scribed by Zelnak, Amelia B.; Styblo, Toncred M.; Rizzo, Monica; Gabram, Sheryl G.; Wood, William C.; Harichand-Herdt, Seema; Kim, Sungjin; Liu, Yuan; O'Regan, Ruth M.

Book ID: 120476514
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 283 KB
Volume: 13
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2012.12.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant bevacizumab, docetaxel and c

Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study

✍ R. Greil; M. Moik; R. Reitsamer; S. Ressler; M. Stoll; K. Namberger; C. Menzel; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Concurrent Bevacizumab with a Sequential

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

✍ Priya Rastogi; Marc E. Buyse; Sandra M. Swain; Samuel A. Jacobs; André Robidoux; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 570 KB

Superior outcome after neoadjuvant chemo

Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer

✍ Chen, Xiaosong; Ye, Guolin; Zhang, Chenfang; Li, Xinzheng; Chen, Yiding; Xie, Xi 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 439 KB

Biomarker results from the AVADO phase 3

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

✍ Miles, D W; de Haas, S L; Dirix, L Y; Romieu, G; Chan, A; Pivot, X; Tomczak, P; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB

Sequential administration of dose-dense

Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

✍ Yago Nieto; José Manuel Aramendía; Jaime Espinós; Susana De la Cruz; Oscar Ferná 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 337 KB

P126 Neoadjuvant treatment of stage II o

P126 Neoadjuvant treatment of stage II or III breast cancer with docetaxel and low dose capecitabine, with addition of trastuzumab for HER 2 amplified tumors

✍ Q.J. Khan; P. Sharma; B.F. Kimler; J. Baranda; J.C. Andersen; J. Klemp; C.J. Fab 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB